Tag : genome sequencing

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported unaudited financial results for the quarter...

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the appointment of Maggie Rougier-Chapman as Senior Vice President, Head of Marketing and...

Total Revenue Increased 166% to $55.1 million; Genomic Volume Grew 215% to 20,856 Tests Company Advanced Clinical Evidence, Pipeline and Global Growth Strategy Raises 2021...

H1 2021 sales impacted by the Covid-19 crisis (-24.6% to €467 thousand) Encouraging upturn in activity in Q2, with sales almost doubling vs. Q1 6.2%...

Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic Oversubscribed round led by SoftBank Vision Fund...

Leader in spatially resolved, single-cell transcriptomics appoints Bob Koshgarian as VP of Operations, advancing company towards MERSCOPE™ commercialization Vizgen, the life science company dedicated to...

Brian Stolz Joins as Chief People Officer, Diana King as VP of Customer Support, and Jordan Neysmith as VP of Engineering Element Biosciences, developer of...

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced expansion plans to support...

Financing led by Patient Square Capital with participation from leading life sciences investors to support the further development of Kriya’s core technology platforms, advancement of...

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers,...